Singapore markets closed

Straits Times Index
3,348.87
+12.28(+0.37%)
S&P 500
5,279.15
+1.64(+0.03%)
Dow
38,555.43
-130.89(-0.34%)
Nasdaq
16,809.87
+74.85(+0.45%)
Bitcoin USD
69,190.55
+1,001.37(+1.47%)
CMC Crypto 200
1,499.51
+31.57(+2.15%)

BMY Jun 2024 37.000 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

4.3100

0.0000

(0.00%)

As of 12:40PM EDT. Market open.

Business Wire
Bristol Myers Squibb’s Breyanzi Demonstrates Clinically Meaningful Outcomes Across Broad Range of B-Cell Malignancies in New Data Presented at 2024 ASCO® Annual Meeting
PRINCETON, N.J., June 03, 2024--BMS' Breyanzi Demonstrates Clinically Meaningful Outcomes Across Broad Range of B-Cell Malignancies in New Data Presented at 2024 ASCO® Annual Meeting
Business Wire
Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations in Early and Advanced Stages of Non-Small Cell Lung Cancer
PRINCETON, N.J., June 03, 2024--Bristol Myers Squibb Presents Multiple New Analyses at 2024 ASCO® Annual Meeting Highlighting Opdivo and Opdivo-based Combinations...
Business Wire
KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Cancer
PRINCETON, N.J., June 01, 2024--KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced....